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The small GTPase ARL2 (from Mus musculus) and an effector
protein, the  subunit of human cGMP phosphodiesterase (hPDE ),
were co-expressed and copuri®ed from Escherichia coli as a stable
complex. Co-expression signi®cantly increased the otherwise low
yield of PDE  production in E. coli. The complex, which contains
ARL2 in the activated GTP-bound form, was crystallized in two
forms. The ®rst belonged to the monoclinic space group P21, with
unit-cell parameters a = 48.1, b = 45.7, c = 74.7 AÊ ,  = 94.0 and one
complex (39 kDa) in the asymmetric unit. Cryocooled crystals
diffracted to 2.3 AÊ using synchrotron radiation. The microfocused
X-ray beam at beamline ID13 (ESRF) allowed the use of very small
crystals, which helped to overcome twinning and enabled the
identi®cation of a molecular-replacement solution. The second form
recrystallized from the ®rst one after several months. These crystals
belonged to the orthorhombic space group P212121, with unit-cell
parameters a = 44.5, b = 65.4, c = 104.4 AÊ and one complex in the
asymmetric unit. They diffracted to 1.8 AÊ using synchrotron
radiation.
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1. Introduction
The ADP-ribosylation factor (ARF) family is
part of the Ras superfamily of small GTPases
and is subdivided into the ARF group (Kahn &
Gilman, 1984) and the group of ARF-like
(ARL) proteins (Tamkun et al., 1991). Ras-like
GTPases act as molecular switches, cycling
between an inactive GDP-bound and an acti-
vated GTP-bound state and are involved in the
regulation of a wide variety of cellular
processes. Both ARF and ARL proteins are
expressed in several isoforms in many tissues.
For ARF proteins, the individual isoforms are
targeted to different cellular membrane
compartments. While the physiological role of
ARF proteins is the regulation of vesicle
formation in intracellular traf®c (Moss &
Vaughan, 1998; Chavrier & Goud, 1999), the
role of ARL proteins is not yet understood.
The  subunit of the human cGMP phospho-
diesterase (hPDE ) was identi®ed as an
interaction partner of RPGR (retinitis
pigmentosa guanine regulator), a protein
responsible for the human hereditary eye
disease X-linked retinitis pigmentosa type III
(Linari, Uef®ng et al., 1999). PDE  then
turned out to interact in a GTP-dependent
manner with ARL3 (Linari, Hanzal-Bayer et
al., 1999) and ARL2 (M. Hanzal-Bayer,
unpublished data), thus representing a putative
effector protein for this group of small
GTPases. PDE  binds speci®cally to ARL3-
GTP and stabilizes this nucleotide state,
thereby increasing the otherwise low af®nity of
ARL3 for GTP (Linari, Hanzal-Bayer et al.,
1999). As a ®rst step towards understanding
ARL proteins on the molecular level, we
recently determined the structure of ARL3-
GDP (Hillig et al., 2000). It revealed an overall
high similarity to ARF1-GDP (Amor et al.,
1994; Greasley et al., 1995), including an
unusual position of the `interswitch region'
between switch 1 and switch 2. This region
constitutes an ARF-speci®c third switch by
which conformational changes of the G
domain modulate membrane af®nity in the
ARF group (Antonny et al., 1997; Goldberg,
1998; BeÂraud-Dufour et al., 1999). We have
initiated a structural analysis of the complex of
ARL2-GTP and PDE . This complex will
reveal the conformation of an ARL protein in
its GTP-bound form which, by comparison
with the closely related ARL3-GDP, will allow
the precise assignment of the switch regions in
this group of GTPases. Knowledge of the exact
conformation of the GTPase is of particular
interest in the ARF family because ARF
isoforms are highly homologous and small
differences at the sequence and structure level
appear to determine targeting to their speci®c
cellular compartments and interaction with
their speci®c effectors and regulators (Mene-
trey et al., 2000). Moreover, the structures of
ARL2-GTP and PDE  will provide the ®rst
structural insights into the interaction between
1168 Renault et al.  ARL2-GTP:PDE  complex Acta Cryst. (2001). D57, 1167±1170
crystallization papers
an effector of the ARF family and its
GTPase. As the physiological function of
PDE  as an effector of ARL proteins is not
yet clear, we expect the structure of the
complex to shed light on the role of this
interaction.
2. Methods and materials
The open reading frames of murine ARL2
(GenBank AF143680) and human PDE 
(GenBank AF045999) were inserted as a
BamHI/HindIII fragment into pGEX KG
(GST-ARL2) and as a BamHI/XhoI frag-
ment into pET28a (His-PDE), respectively.
Cells of the methionine auxotroph E. coli
strain B834 (Novagen) were transformed
with both plasmids simultaneously and each
colony obtained was tested for co-expres-
sion of both proteins. Strain B834 was
chosen to enable production of the seleno-
methionine-labelled proteins at a later stage
(see below). The cells were used to inoculate
a 5 l culture in Terri®c Broth medium
supplemented with 50 mg mlÿ1 ampicillin
and 25 mg mlÿ1 kanamycin. Cells were
grown at 310 K to an OD600 of 0.8, where-
upon expression was induced with 0.6 mM
IPTG. After 1 h at 310 K, incubation was
prolonged at 291 K overnight. Cells were
harvested, shock frozen in liquid nitrogen
and resuspended immediately in 100 ml
TMMG buffer (50 mM Tris±HCl, 10 mM
MgCl2, 5 mM -mercaptoethanol, 1.7 mM
GTP pH 7.5) with 0.4%(w/v) sodium deox-
ycholate and two tablets of Complete
protease inhibitor (Boehringer). After
treatment with DNaseI for 20 min at 277 K,
cells were passed through a ¯uidizer and
centrifuged at 100 000g. The supernatant
was applied onto a GSH Sepharose 4B
column equilibrated in TMMG buffer. After
extensive washing of the column, cleavage of
the tags was carried out with 1200 units
thrombin (Serva) overnight. About 120 mg
of a complex between PDE  and ARL2
were eluted in TMMG buffer, concentrated
by ultra®ltration and applied onto a
Superdex S75 gel-®ltration column, from
which the complex eluted in the expected
volume. Additionally, the identity of both
proteins was veri®ed by mass spectrometry
and N-terminal sequencing. The complex
was concentrated to 29 mg mlÿ1, dialysed
against 50 mM Tris±HCl, 10 mM MgCl2,
5 mM -mercaptoethanol, 5 mM GTP
pH 7.5 and stored ¯ash-frozen at 193 K.
For the production of the selenomethio-
nine-labelled complex (Doublie, 1997),
E. coli B384 cells were grown in LeMaster
minimal medium (Hendrickson et al., 1990)
with 200 mg lÿ1 ampicillin, 100 mg lÿ1
kanamycin and 50 mg lÿ1 methionine at
291 K and selenomethionine was substituted
for methionine at gradual intervals. Protein
production was then performed in a 16 l
culture with 50 mg lÿ1 selenomethionine.
Prior to inoculation, cells were tested for
methionine-independent growth and co-
expression of both proteins. It was necessary
to lower the temperature to 291 K and to
reduce the IPTG concentration to 0.2 mM to
keep the complex soluble. Puri®cation was
performed as described for the wild type.
Crystals were grown using the hanging-
drop method. All setups were performed at
277 K to minimize GTP hydrolysis. Initial
conditions were identi®ed in a PEG screen
for 5±10% PEG 6000 at pH 6.0±8.0. Fine-
tuning of the condition and extensive streak
seeding [in drops consisting of 1 ml protein
solution and 1 ml reservoir (9±12% PEG
5000 MME, 0.1 M HEPES pH 7.0) and
which were pre-equilibrated for 1.5 h over
1 ml reservoir] resulted in larger rod-shaped
crystals. The identity of the crystallized
material was checked by SDS±PAGE and
mass spectrometry of thoroughly washed
crystals. The selenomethionine complex
crystallized under the same conditions as the
wild type. After storage of the crystallization
setups for several months at 277 K, a second
crystal form was found which recrystallized
from the ®rst one.
For the ®rst crystal form, a native data
set (`Native-1') to 2.3 AÊ resolution was
collected from one crystal on a MAR CDD
detector at the microfocus beamline ID13
(ESRF, Grenoble). The crystal was quickly
transferred in two steps into 15% PEG 5000
MME/30% glycerol as cryoprotectant and
¯ash-cooled to 100 K immediately prior to
data collection. The data-collection statistics
are given in Table 1. For the second crystal
form, a native data set to 1.8 AÊ resolution
(`Native-2') was collected at beamline BW6
(DESY, Hamburg) using 15% PEG 5000
MME/15% glycerol/10% xylitol as cryo-
protectant. In addition, a SAD data set
(`SeMet') for crystal form 2 to 2.6 AÊ
resolution was collected from a seleno-
methionine-labelled crystal using a MAR
CCD detector at beamline ID13 (ESRF,
Grenoble), with 20% PEG 5000 MME/10%
PEG 400 as cryoprotectant. All diffraction
data were processed using DENZO and
SCALEPACK (Otwinowski & Minor,
1997).
3. Results and discussion
Murine ARL2 comprising residues 1±184
fused via an amino-terminal linker to GST
and human PDE  comprising residues
1±150 with an additional amino-terminal His
tag were co-expressed in E. coli B834. Cells
with both plasmids produced considerably
more PDE  than cells expressing PDE 
alone and, judging from SDS±PAGE
analysis, GST-ARL2 and His-PDE  were
always produced in a 1:1 ratio. This was
taken as evidence that both proteins already
form a complex in E. coli and that GST-
ARL2 stabilizes the expression of His-
PDE . After af®nity chromatography via
the GST-tag of ARL2, thrombin cleavage
removed both the amino-terminal His tag of
PDE  and the amino-terminal GST-fusion
Table 1
Data-collection statistics for different crystals of ARL2:PDE .
Native-1
(crystal form 1)
Native-2
(crystal form 2)
SeMet
(crystal form 2)
Crystal dimensions (mm) 10  60  300 400  400  400 30  80  100
X-ray source ID 13 (ESRF) BW 6 (DESY) ID 13 (ESRF)
Wavelength (AÊ ) 0.782 1.005 0.964
Detector MAR CCD MAR CCD MAR CCD
Crystal-to-detector distance (mm) 150 200 (low), 108 (high)² 150
Total rotation scan () 130 100 (low), 194.6 (high)² 209
Exposure time (s)/oscillation range () 2/1 5/1 (low), 12/0.2 (high)² 6/1
Space group P21 (No. 4) P212121 (No. 19) P212121 (No. 19)
Unit-cell parameters
a (AÊ ) 48.1 44.5 44.8
b (AÊ ) 45.7 65.4 65.7
c (AÊ ) 74.7 104.4 104.0
 () 94.0 90.0 90.0
Mosaicity () 0.45 0.61 1.20
Resolution range (AÊ ) 19.7±2.3 34.7±1.8 19.8±2.6
Highest resolution shell (AÊ ) 2.35±2.30 1.84±1.80 2.65±2.60
Total No. of re¯ections 41852 248895 86108
No. of unique re¯ections 14251 28815 9926
Multiplicity³ 2.9 (3.0) 8.6 (7.9) 8.7 (9.6)
Completeness³ (%) 97.5 (99.7) 99.5 (98.9) 99.6 (100.0)
Rsym³ 0.065 (0.235) 0.042 (0.316) 0.081 (0.391)
I/(I)³ 14.8 (5.8) 38.8 (4.8) 25.1 (7.0)
² Data set `Native-2' was collected in two sweeps, a low- and a high-resolution sweep (detector edge at 2.7 and 1.7 AÊ ,
respectively). ³ Values in parentheses refer to the highest resolution shell.
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of ARL2 in one step. The eluted protein
fractions were further puri®ed by gel ®ltra-
tion, which showed a homogenous peak for
the stable ARL2:PDE  complex. As PDE 
shows high binding af®nity only to the GTP-
bound state of ARL2 (M. Hanzal-Bayer,
unpublished work) and inhibits dissociation
of GTP once it is bound, we expected the
puri®ed complex to contain ARL2 in the
GTP-bound form and will refer to it as
ARL2-GTP:PDE  hereafter.
The initially observed clusters of micro-
needles of crystal form 1 (Fig. 1a) grew
within 1±5 d and were improved by streak
seeding to form rod-shaped crystals with
typical dimensions of 30  50  400 mm
(Fig. 1b). SDS±PAGE analysis of washed
crystals (Fig. 2, lane 2) con®rmed the
presence of both ARL2 and PDE . Mass
spectrometry con®rmed the identity of
the molecules and the expected thrombin
cleavage site: the obtained masses
(21 006 Da for ARL2 and 17 562 Da for
PDE ) correspond to the expected values
for the native sequences with an additional
Gly-Ser at each amino terminus as a cloning
artefact and the mutation Ser33Leu in
ARL2 introduced accidentally by PCR
(ARL2 expected MW, 21 008 Da; PDE 
expected MW, 17 564 Da). A Leu is found in
this position in the closely related protein
ARL3 which interacts with PDE  in a
similar manner (Linari, Hanzal-Bayer et al.,
1999). Therefore, we do not consider the
Ser33Leu mutation to show an effect on the
interaction with PDE .
In a ®rst set of experiments on crystals
of form 1 at beamline BM30 (ESRF,
Grenoble), all the crystals tested exhibited
varying degrees of twinning. A 2.7 AÊ data
set was collected from a rod-shaped crystal
(40  60  300 mm) which showed rela-
tively little twinning (data not shown).
However, all attempts to solve the phase
problem by molecular replacement using
AMoRe (Navaza & Saludjian, 1997) with
different search models failed with this data
set. As smaller crystals showed less twinning,
we collected an additional native data set
from a crystal of only 10  60  300 mm in
size using the microfocused X-ray beam at
beamline ID13 (ESRF, Grenoble). This
crystal diffracted to better than 2.3 AÊ and
was indeed devoid of twinning (for statistics,
see Table 1). It belongs to the monoclinic
space group P21, with unit-cell parameters
a = 48.1, b = 45.7, c = 74.7 AÊ ,  = 94.0. The
Matthews parameter suggests one complex
per asymmetric unit, with VM = 2.1 AÊ
3 Daÿ1
(solvent content 41%). In this case, mole-
cular replacement using AMoRe resulted in
clear solutions both for ARL3-GDP (Hillig
et al., 2000) and ARF117-GppNHp
(Goldberg, 1998) as search models, produ-
cing identical orientations with both models.
Electron-density maps calculated with
molecular-replacement phases derived from
search models where the nucleotide was
omitted showed clear density for a nucleo-
tide with three phosphates, thereby
con®rming that ARL2 did indeed crystallize
in the GTP-bound form. Probably owing
to an incomplete molecular-replacement
search model, the electron density for PDE 
was not yet interpretable.
Meanwhile, a second crystal form with
more compact morphology was found in
crystallization setups stored for several
months at 277 K (Fig. 1c). The crystals
recrystallize from the rod-shaped crystals of
form 1. This process started spontaneously
and only in very few of the drops. After a
year, however, the transformation had taken
place in the majority of the drops and
produced large crystals (Fig. 1d). SDS±
PAGE also con®rmed the presence of both
proteins in these crystals. One of these
crystals was used to collect a native data set
to 1.8 AÊ resolution (`Native-2' in Table 1) on
the MPG/GBF wiggler beamline BW6/
DORIS (DESY, Hamburg). It showed
roughly octahedral morphology with edges
of 400 mm each and was found in a drop
which, at the time of data collection, had
been stored for 13 months at 277 K. The
space group of this crystal form is P212121,
with unit-cell parameters a = 44.5, b = 65.4,
c = 104.4 AÊ . The Matthews parameter is
2.0 AÊ 3 Daÿ1 (solvent content 37%) for one
complex per asymmetric unit. Molecular-
replacement attempts with this data set once
again revealed density for three phosphates
in the nucleotide-binding site, although the
search models were still insuf®cient to
produce interpretable density for PDE . We
therefore initiated the production of the
selenomethinine complex (see x2) to solve
the phase problem by MAD or SAD
phasing. We expected that three methio-
nines in ARL2 and ®ve methionines in
Figure 1
Crystals of ARL2-GTP:PDE . (a) Clusters of microneedles of crystal form 1 as found with the initial condition.
(b) Selenomethionine crystals of crystal form 2 (maximum size about 30  80  100 mm) as used for data set
`SeMet'. (c) Rod-shaped crystals optimized by streak seeding as used for data collection. The largest rod has
dimensions of 20  40  800 mm. (d) Large native crystals of form 2 (edges 400 mm) as used for `Native-2',
found 13 months after setting up of the drop. In the background aged needle bundles of crystal form 1 are still
visible.
Figure 2
SDS±PAGE analysis of washed and dissolved crystals
of crystal form 1. Lane 1, mother liquor taken from
crystallization drop; lane 2, washed crystals; lane 3,
protein solution as used for crystallization.
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PDE  would be suf®cient for successful
phasing. Initially, we obtained very thin
needles of crystal form 1 which were in-
appropriate for data collection. However, a
crystal of form 2 (30 80 100 mm in size;
Fig. 1c) allowed collection of a SAD data set
to 2.6 AÊ resolution at the microfocus
beamline ID13 (ESRF, Grenoble; data set
`SeMet' in Table 1).
With the data set `SeMet', we succeeded
in improving the quality of the electron-
density maps by a combination of molecular
replacement and SAD phasing. Preliminary
data indicate that the core of PDE  is
appreciably interpretable in both crystal
forms. However, some of the loops of PDE 
appear to be well ordered only in form 2,
which seems to be a result of better crystal
packing. Model building and re®nement in
both crystal forms is in progress and will be
described elsewhere, together with the
structure and the detailed phasing proce-
dure.
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